IWA
RANI icon

Icon Wealth Advisors’s Rani Therapeutics RANI Stock Holding History

Icon Wealth Advisors’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$75.3K Buy
+12,757
New +$93.1K 0.01% 321

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
ASGS
Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TWA
TPB Wealth Advisors San Antonio, Texas $183M AUM 9.21% 1-Year Est. Return

Icon Wealth Advisors's RANI Position: Q4 2022 in Review

Icon Wealth Advisors opened a new position in Rani Therapeutics (RANI) in Q4 2022: 12,757 shares worth $75.3K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings.

34 funds tracked by Wall St. Rank hold RANI as of Q4 2022.

  • Icon Wealth Advisors held 12,757 shares of Rani Therapeutics worth $75.3K as of Q4 2022.
  • Rani Therapeutics was a new Icon Wealth Advisors position in Q4 2022.
  • Rani Therapeutics made up 0.01% of Icon Wealth Advisors's portfolio in Q4 2022, its #321 holding.
  • 34 funds tracked by Wall St. Rank held Rani Therapeutics as of Q4 2022.

Based on Icon Wealth Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.